MedTrace Logo

Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients

NCT05680363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2026-01-08

No results posted yet for this study

Summary

Prospective, multi-centric, split-sample, sibling oocyte study evaluating the safety and efficacy of a new method to prepare sperm samples for IVF (in vitro fertilization) / ICSI (intracytoplasmic sperm injection) compared to standard procedures.

Conditions

Interventions

DEVICE

HyperSperm

Multi-step sperm preparation

DEVICE

Standard Sperm Preparation

Standard sperm preparation

Sponsors & Collaborators

  • Fecundis S.A.

    lead OTHER

Principal Investigators

  • Mariano Buffone, PhD · Fecundis Lab SL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
41 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-12-18
Completion
2025-12-18

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05680363 on ClinicalTrials.gov